New research study for patients with Type 2 Diabetes who are currently using long-acting insulin

About the Study

This study is looking for patients with Type 2 Diabetes who are currently using long-acting insulin. Patients will either remain on their insulin or will have a once-weekly study injection added to reduce the amount of insulin taken.

The once-weekly study injection is already approved on the market.

Study participants may receive study-related care and study medication or an approved medication at no charge. You may also receive compensation for travel expenses.

Participant Eligibility Criteria ( To take part in the study )

• Type 2 Diabetes
• A1C between 7.0 and 9.0%
• Currently using long-acting insulin